- Home
- KRRO vs DTIL Comparison
KRRO vs DTIL Comparison
Compare KRRO & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRRO | DTIL |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.1M | 97.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KRRO | DTIL |
|---|---|---|
| Price | $11.63 | $4.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | $54.60 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 294.9K | 211.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $145.97 | N/A |
| Revenue Next Year | N/A | $34.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.20 | $3.53 |
| 52 Week High | $55.89 | $8.82 |
Technical Indicators
Market Signals| Indicator | KRRO | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 51.81 | 48.88 |
| Support Level | $10.81 | $3.62 |
| Resistance Level | $12.46 | $4.11 |
| Average True Range (ATR) | 1.11 | 0.25 |
| MACD | -0.12 | 0.04 |
| Stochastic Oscillator | 16.69 | 76.42 |
Price Performance
Historical ComparisonAbout KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.